-
1
A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors
Published 2025-04-01“…Journal of Bone Oncology…”
Get full text
Article -
2
Out with the old (not so!) and in with the new
Published 2025-02-01“…Journal of Bone Oncology…”
Get full text
Article -
3
Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets
Published 2025-04-01“…Journal of Bone Oncology…”
Get full text
Article -
4
Naringenin induces ferroptosis in osteosarcoma cells through the STAT3-MGST2 signaling pathway
Published 2025-02-01“…Journal of Bone Oncology…”
Get full text
Article -
5
Mixed reality infrastructure based on deep learning medical image segmentation and 3D visualization for bone tumors using DCU-Net
Published 2025-02-01“…Journal of Bone Oncology…”
Get full text
Article -
6
Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS
Published 2025-02-01“…Journal of Bone Oncology…”
Get full text
Article -
7
Using β-Elemene to reduce stemness and drug resistance in osteosarcoma: A focus on the AKT/FOXO1 signaling pathway and immune modulation
Published 2025-02-01“…Journal of Bone Oncology…”
Get full text
Article -
8
Radiomics analysis of thoracic vertebral bone marrow microenvironment changes before bone metastasis of breast cancer based on chest CT
Published 2025-02-01“…Journal of Bone Oncology…”
Get full text
Article